DefEYE
Latest round
- Seed
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 1
About DefEYE
DefEYE, Inc. focuses on providing biologic solutions for ocular health. The company has undergone strategic shifts to enhance its offerings and is headquartered in the United States. In November 2025, DefEYE, Inc. Their flagship product, BIOVANCE® 3L Ocular, utilizes a unique triple-layer design that facilitates improved healing for various eye conditions, including persistent epithelial defects and pterygium surgery. These products are intended for use by healthcare professionals in the field of ophthalmology, targeting both surgical procedures and ongoing management of ocular diseases. DefEYE™ products are primarily marketed to hospitals, outpatient surgical centers, and ophthalmic practices across the United States, reflecting a commitment to advancing ocular care through evidence-based solutions.DefEYE™, Inc. generates revenue through direct sales of its biologic solutions to healthcare providers and institutions. The company employs a business-to-business model, catering to hospitals and surgical centers that incorporate its products into their treatment protocols. Transactions are structured around product orders, with practitioners purchasing BIOVANCE® 3L Ocular and related offerings as needed to address specific patient cases. This transactional framework allows for tailored solutions based on the unique needs of individual patients, supporting the company's mission to improve ocular health.In November 2025, DefEYE, Inc. Future initiatives include the launch of new products specifically designed for ocular treatments, with plans to enter new markets in North America and Europe by 2026. The strategic expansion aims to broaden their reach and enhance their product offerings in the global ophthalmic market.
Who invested in DefEYE
1 investor across 1 round
See all investors in DefEYE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 6, 2025
Amount
Undisclosed
Investors
Questions about DefEYE
Who invested in DefEYE?
DefEYE has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DefEYE raised?
DefEYE has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DefEYE last raise money?
DefEYE's most recent round on record is a Seed, in Nov 2025.
What does DefEYE do?
DefEYE is a healthcare specialists company.
Where is DefEYE headquartered?
DefEYE is headquartered in US.
Which VCs invest in companies like DefEYE?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at DefEYE's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like DefEYE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.